Special Promotion: Humanized Models for Oncology Research (March–June)

Accelerate your oncology research with GenoBioTX's humanized animal models. From March 1st to June 30th, we are offering a special promotion to support groundbreaking advancements in cancer research.

Disease-Specific Humanized Models

GenoBioTX provides a diverse range of humanized models tailored for high translational relevance across multiple disease areas, including:

Oncology & Immuno-Oncology (Promotion Available)

  • Tumor growth/metastasis models
  • CAR-T and bispecific antibodies
  • Checkpoint inhibitors
  • Patient-derived xenograft (PDX) models

Neurology

  • Neuroinflammation
  • ALS, Parkinson’s disease
  • CNS-targeted therapies

Autoimmune Diseases

  • Preclinical models for lupus, rheumatoid arthritis, inflammatory bowel disease (IBD), and multiple sclerosis

Cardiometabolic Diseases

  • Atherosclerosis
  • Diabetes, obesity
  • Metabolic syndrome research

Rare Diseases

  • Humanized models for genetic disorders and rare metabolic conditions

Find the Best Model for Your Research

We offer an extensive selection of humanized animal models designed to meet the needs of various preclinical studies. Our team of experts is available to guide you in selecting the most suitable models for your research goals.

📩 Contact us today to discuss your project and take advantage of this limited-time promotion.

    News Center

    2024.11.01

    New Service Launch: Mouse Bone Metastasis Cancer Model and Pain-Related Behavior Assessment!

    What is Bone Cancer Pain?  Cancer-induced Bone Pain (CIBP) or Bone Cancer Pain (BCP) is a type of pain caused by the invasion of tumors (such as primary bone tumors or bone metastases from breast cancer, prostate cancer, bladder cancer, lung cancer, etc.) into the bones [1]. This pain can severely impact a patient’s mental state […]

    2024.11.09

    Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development

    Registration link: https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator Date: Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST Webinar Highlights: Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating […]

    Email Back to top